Avicenna Alliance: enhanced knowledge, improved decisions, better outcomes

Policy makers

In silico methods, or using computer modelling and simulation (CM&S), is utilised to amplify and accelerate the design, development, testing and regulatory approval of new medical treatments. To achieve this goal, the healthcare community needs a clear and harmonised regulatory framework to ensure the necessary credibility of this approach for maximising patient safety while accelerating medical innovation.

In the last decade, policy makers from around the world have paid an increasing attention to this technology having the promise to accelerate medical innovation and make health care safer, more affordable, more effective and more efficient for their citizens. In addition, adopting this technology, widely used in other industries (such as aerospace, automotive or hightech among others), is also giving a clear competitive advantage to the industrial healthcare community operating in their region.

In leading regions, policy makers have facilitated research funding and built the legislative framework to validate computational models and encouraged their usage in faster regulatory approval process without compromising with safety and effectiveness for the benefits of local citizen and industries.


News Avicenna at eHealth Stakeholders group meeting

Avicenna at eHealth Stakeholders group meeting

Very interesting exchanges yesterday, during the meeting of the e-health stakeholders group organized by the European Commission.

News Avicenna Alliance at University of Toulouse

Avicenna Alliance at University of Toulouse

On February 9, Noemie Dubruel, active member of the Avicenna Alliance as a doctoral student in Droit de la santé et de la recherche médicale at the University of Toulouse 1 Capitole and Thierry Marchal spoke at the Consortium Santé in silico 6 on synthetic data and simulation in the service of clinical research, organized by Nicolas Savy.

News Abimed is a new Avicenna Partner!

Abimed is a new Avicenna Partner!

We are delighted to welcome Abimed as a new Avicenna Partner.

Sign up for our monthly newsletter!

Sign up for our monthly newsletter!

Fill in the fields you find below

Avicenna Alliance is an initiative of:

Avicenna VPH

© 2018-2024 Avicenna Alliance | powered by We Berry